A poor prognosis in patients with GBM was shown to be correlated with high SphK1 expression [9], and the inhibition of SphK1 results in the growth arrest of GBM cells both in vitro and in vivo [9,10]. This evidence concerns the gene SPHK1 and glioblastoma.